ALX Oncology Holdings, Inc. (ALXO)
2.00
+0.01
(+0.50%)
USD |
NASDAQ |
Aug 25, 16:00
2.00
0.00 (0.00%)
After-Hours: 19:59
ALX Oncology Holdings Total Liabilities (Quarterly) : 24.63M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.63M |
| March 31, 2026 | 26.98M |
| December 31, 2025 | 33.06M |
| September 30, 2025 | 37.92M |
| June 30, 2025 | 30.90M |
| March 31, 2025 | 32.60M |
| December 31, 2024 | 34.16M |
| September 30, 2024 | 48.91M |
| June 30, 2024 | 55.30M |
| March 31, 2024 | 48.46M |
| December 31, 2023 | 52.84M |
| September 30, 2023 | 51.36M |
| June 30, 2023 | 33.24M |
| March 31, 2023 | 37.75M |
| Date | Value |
|---|---|
| December 31, 2022 | 43.02M |
| September 30, 2022 | 30.73M |
| June 30, 2022 | 29.70M |
| March 31, 2022 | 20.08M |
| December 31, 2021 | 17.13M |
| September 30, 2021 | 14.56M |
| June 30, 2021 | 16.28M |
| March 31, 2021 | 14.43M |
| December 31, 2020 | 6.209M |
| September 30, 2020 | 10.43M |
| June 30, 2020 | 12.47M |
| March 31, 2020 | 9.282M |
| December 31, 2019 | 10.95M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.641M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 160.82M |
| Shareholders Equity (Quarterly) | 136.19M |
| Debt to Equity Ratio | 0.0811 |
| Current Ratio | 9.709 |
| Net Debt Paydown Yield | 0.39% |